Management of arrhythmias in patients with chronic kidney disease on hemodialysis

Main Article Content

León Murillo Javier Alejandro
Andrés Santiago Bueno Castro


Chronic kidney disease; Hemodialysis; arrhythmias; Oral anticoagulants; Driving


Hemodialysis is an effective treatment that helps control blood pressure and compensate for important minerals in the bloodstream of a patient diagnosed with chronic kidney disease; However, this population group also denotes its significant vulnerability to developing certain cardiovascular complications such as cardiac arrhythmias, which not only condition the success of the procedure, but can also put the individual's survival at risk.
Objective: To describe the current management based on scientific evidence of arrhythmias in patients with chronic kidney disease on hemodialysis.
Methodology: This bibliographical review contemplates a search, analysis and synthesis process of different theoretical foundations, obtained from duly validated scientific information sources, which provide reliable support to achieve the established objectives.
Results: Ventricular and supraventricular arrhythmias are frequent disorders that appear in hemodialysis. The management of these conditions addresses continuous monitoring, synchronized electrical cardioversion, administration of calcium antagonists, anticoagulants, warfarin, amiodarone, acetylsalicylic acid and other antiarrhythmic drugs such as lidocaine and procainamide.
Conclusion: Among the oral anticoagulants that are most frequently used to prevent such events are vitamin K antagonists (VKAs), such as warfarin, and those that are not antagonists or opposed to vitamin K (NOACs), such as apixaban. , Dabigatran, Edoxaban and Rivaroxaban.

Abstract 374 | PDF Downloads 182


1. De La Guardia M, Ruvalcaba J. Health and its determinants, health promotion and health education. J Negat No Posit Results [Internet]. 2020;5(1):81–90. Available from:
2. Centro de Diagnóstico Servicios Integrales de la Salud [CDSIS]. Great discoveries in the history of medicine [Internet]. Discoveries in medicine. 2020 [cited 2023 Mar 10]. Available from:
3. Mercado F, Huerta V, Urias J. Virtual social networks and Health. A participatory experience on chronic kidney disease. Interface - Comun Saúde, Educ [Internet]. 2019;23. Available from:
4. World Health Organization [WHO]. Chronic kidney disease [Internet]. Fact sheet. 2020 [cited 2023 Apr 10]. Available from: signs and symptoms of,mental acuity%2C muscle spasms and
5. Cerón M, Sánchez C. Assessment of a food education in patients with chronic renal failure in predialysis. Rev San Gregor [Internet]. 2019 Oct 1;1(33). Available from:
6. Gonzalez M, Rosa G, Ferreiro A. The Latin American Registry of Dialysis and Kidney Transplantation: the importance of the development of national registries in Latin America. Nefrol Latinoam [Internet]. 2017 Jan;14(1):12–21. Available from:
7. Latin American Society of Nephrology and Hypertension [SLNH]. The Latin American Society of Nephrology and Hypertension and the challenges of chronic kidney disease in our region [Internet]. Articles. 2020 [cited 2023 Apr 10]. Available from:ía-e-hipertensión-y-los-retos-de-la-enfermedad-renal-crónica-en-nuestra-región
8. Ministry of Public Health of Ecuador [MSP]. Current Situation of Therapy Renal Replacement in Ecuador [Internet]. Technical Report. 2022 [cited 2023 Apr 10]. p. 1–17. Available from:
9. Pillajo B, Guacho J, Moya I. Chronic kidney disease. Review of literature and local experience in a city in Ecuador. Rev Da Vida [Internet]. 2022;19(10):17–23. Available from:
10. Malkina A. Chronic kidney disease or chronic kidney disease [Internet]. MSD MANUAL Version for general public. 2021 [cited 2023 Apr 10]. Available from:ónica-o-nefropatía-crónica
11. Suárez A, Otero J, Rosabal A, Miranda S. Ventricular arrhythmias in patients with end-stage chronic kidney disease on hemodialysis. Intradialytic Holter monitoring. Rev Habanera Medical Sciences [Internet]. 2019;13(4):516–30. Available from:
12. Estenoz G, Álvarez M. Quality control and management in hemodialysis. Rev MediSan [Internet]. 2019;15(5):657–65. Available from: hemodialysis (HD) is severe metabolic hypercalcemia and acidosis.
13. Bardajía A, Martínez A. Chronic kidney disease and heart. An evolutionary continuum. Chronic Kidney Dis Hear Linked Pathol [Internet]. 2019;61(52):41–51. Available from: chronic kidney disease this, increased morbidity and mortality observed
14. López J, Vega A. Cardiovascular Alterations in Chronic Kidney Disease. Rev la Soc Española Nefrol [Internet]. 2020;24(6):14–27. Available from:
15. Cedeño S, Vega A, Macías N, Sánchez L, Abad S, López J, et al. Definitions of intradialysis hypotension with predictive power of mortality in a hemodialysis cohort. Nephrology [Internet]. 2020 Jul;40(4):403–13. Available from:
16. Reyes F, Pérez M, Figueredo E, Núñez E, Jiménez K. Atrial fibrillation. Overview of an updated topic. Medical Scientific Mail [Internet]. 2018;22(4):695–718. Available from: atrial fibrillation (AF) is, with socioeconomic and health impact.
17. Candelaria J, Gutierrez C, Bayarre H, Acosta C, Montes D, Labrador O. Characterization of chronic kidney disease in older adults. Rev Colomb Nefrol [Internet]. 2019 Aug22;5(2):166. Available from:
18. Carrillo M, Rodríguez L, Díaz R, Cervera M, Constantino F. Prevention of chronic kidney disease in adults: a literature review. Nephrological Nursing [Internet]. 2022 Dec 30;25(4):310–8. Available from:
19. Cen R, Hernández K, Mena S, Zamora D, Zeledón J, Herrera A. Chronic kidney disease. Rev Clínica la Esc Med UCR-HSJD [Internet]. 2020;10(4):58–66. Available from:
20. Martínez L, Rojas L, Garciga M, Iglesias A, Miranda D. Knowledge about Chronic Kidney Disease in Psychology students from Cuba. Rev Horiz Enferm [Internet]. 2020;29(20):291–305. Available from:
21. García R, Bover J, Segura J, Goicoechea M, Cebollada J, Escalada J, et al. Information and consensus document for the detection and management of chronic kidney disease. Rev Nefrol [Internet]. 2022 May;42(3):233–64. Available from:
22. Obando S, Chamorro R, Chavarría S, Garcés N. Exacerbated chronic kidney disease. ReciaMuc [Internet]. 2022 May 4;6(2):324–31. Available from:
23. García C, Aran L, Vilela Á, Amat G, Ortíz S, Giralt M. Identification of underdiagnosis of chronic kidney disease in primary care. Enferm Nefrol [Internet]. 2019;22(3):302–7. Available from:
24. Nieto J, García C, Vesga D, Obregón M, Serna L. Chronic kidney disease of agricultural communities, a literature review. Iatreia [Internet]. 2022 Apr 1;35(2):131–40. Available from:
25. Cueva Á, Neach D, Ortiz W, Fernández J, Lara S, Chi S, et al. Protocol for the prevention of ventricular arrhythmias due to treatment in patients with COVID-19. Arch Cardiol México [Internet]. 2021 Sep 30;90(91). Available from:
26. Gonzales A, Segura P, León R, Laurente J, Ríos P. Arrhythmia-induced cardiomyopathy: case report. Arch Cardiol México [Internet]. 2021 Nov 1;91(3). Available from:
27. Ramos M. Highlights of the Consensus Document for the Management of Asymptomatic Arrhythmias. Rev Uruguaya Cardiol [Internet]. 2019 Jul 1;34(2). Available from:
28. Isa R. Arrhythmias in asymptomatic patients. Rev Chil Cardiol [Internet]. 2019 Apr;38(1):70–1. Available from:
29. Amado J, Tazza F, Vargas M. Almost fatal ventricular arrhythmia associated with the use of psychotropic drugs. An la Fac Med [Internet]. 2019 Oct 10;80(3):346–9. Available from:
30. Zambrano E, Ollague R, Quisilay B, Velasco L. Mechanisms of cardiac arrhythmias. ReciMundo [Internet]. 2019 Sep 30;3(3):717–34. Available from:
31. Esparza C, García J, Reyes E, García L. Management of cardiac arrhythmias in first-level health units. Rev Polo del Conoc. 2019;4(10):118–35.
32. Patiño D, Medina J, Silva R, Guijarro A, Rodríguez J. Prediction of Arrhythmias and Acute Myocardial Infarctions using Machine Learning. Ingenius [Internet]. 2023 Jan 1;(29):79–89. Available from:
33. Carcasés S, Rodríguez A, Lamorú R, Hernández F. Clinical characterization and treatment of patients with atrial fibrillation. Rev Cuba Med Mil [Internet]. 2022;51(4). Available from:
34. Platero A, Cruz J, Rodríguez H. Presentation of cardiovascular alterations in dialysis patients. Rev InfoMed [Internet]. 2021;9(1). Available from:
35. López J, Vega A. Cardiovascular Alterations in Chronic Kidney Disease. Rev Nefrol up to date. 2020;18(4).
36. Figuer A, Alique M, Valera G, Serroukh N, Ceprían N, Sequera P, et al. New mechanisms involved in the development of cardiovascular disease in chronic kidney disease. Nefrología[Internet]. 2023 Jan;43(1):63–80. Available from:
37. Merino M, Salto J, Ibarra M, Montesdeoca PG. Indications for hemodialysis in the emergency room. ReciaMuc [Internet]. 2020 Jan 31;4(1):71–82. Available from:
38. Sequeira O, Torales J, García L, Centurión O. Diagnostic evaluation and pharmacological therapeutic management in patients with atrial fibrillation. Memoirs of the Institute of Research in Health Sciences [Internet]. 2019 Aug 12;17(2):86–101. Available from:
39. Pugliese I, Perafán P, Llanos N, Martínez H, Vesga C, Amaya P. Atrial appendage closure in atrial fibrillation and high risk of bleeding: case series. Acta Neurológica Colomb [Internet]. 2022 Nov 24;38(4):191–200. Available from:
40. Cuevas M, Saucedo R, García P, Pacheco A, Gómez M, González M, et al. Factors associated with the development of adverse events in hemodialysis patients in Guerrero, Mexico. Nephrological Nursing [Internet]. 2019 Mar 22;22(1):42–50. Available from:
41. W. Kings The best of the ACC Congress 2021. Rev Uruguaya Cardiol [Internet]. 2021 Mar 17;36(12):1–16. Available from:
42. Wang X, Ouyang M, Yang J, Song L, Yang M, Anderson C. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev [Internet]. 2021 Oct 22;2021(12). Available from:
43. Ameriso S, Pujol V. Neurological perspective in the choice of direct oral anticoagulant for the prevention of stroke in atrial fibrillation. Rev InfoMed [Internet]. 2022;82(22):93–7. Available from:
44. Chao T, Nedeljkovic M, Lip G, Potpara T. Stroke prevention in atrial fibrillation: comparison of recent international guidelines. Eur Hear J Suppl [Internet]. 2020 Dec 22;22(Supplement_O):O53–60. Available from:
45. Shields A, Lip G. Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation. J Intern Med [Internet]. 2019 Jul;278(1):1–18. Available from:
46. Evaristo L, Cunha A, Morais C, Samselski B, Esposito E, Miranda M, et al. Complications during the hemodialysis session. Av en Enfermería [Internet]. 2020 Sep 1;38(3):316–24. Available from:
47. Méndez N, Rodríguez V, Orellana A, Valenzuela S. Nursing intervention in the health promotion of people on hemodialysis, a view from the discipline: Integrative review. Nursing Care Humaniz [Internet]. 2020 May 15;9(1):52–62. Available from:
48. Meneses V, Medina M, Gómez M, Cruzalegui C, Alarcón C. Renal failure and hemodialysis in hospitalized patients. ACTA MEDICA Peru [Internet]. 2022 Feb 4;38(4). Available from:
49. Zamora C, Moreno A, Cabrera A, Regalado L, Amato J. Patient experiences before the diagnosis of chronic kidney disease and admission to peritoneal dialysis. Nephrological Nursing [Internet]. 2022 Mar 30;25(1):59–65. Available from:
50. Guzman W, Caballero J. Survival of patients on chronic hemodialysis versus chronic peritoneal dialysis. Rev Peru Med Exp Salud Publica [Internet]. 2022 Jul 11;39(2):161–9. Available from:
51. Santana M, Silva D, Lopes S. Life after hemodialysis. Texto Context - Enferm [Internet]. 2020;29(spe). Available from:
52. Santana M, Silva D, Lopes S, Romanoski P, Böell J. Self-care in individuals with chronic kidney disease on hemodialysis. Rev Gaúcha Enferm [Internet]. 2020;41. Available from: